Nav: Home

Lowering blood pressure prevents worsening brain damage in elderly

March 18, 2019

New Orleans, LA (Mar 18, 2019) - Elderly people with high blood pressure, or hypertension, who took medicine to keep their 24-hour systolic blood pressure around 130 mm Hg for three years showed significantly less accumulation of harmful brain lesions compared with those taking medicine to maintain a systolic blood pressure around 145 mm Hg, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. However, the reduction in brain lesions, visible as bright white spots on a magnetic resonance imaging (MRI) scan, did not translate to a significant improvement in mobility and cognitive function. Researchers said it is likely that three years was too short a time for such benefits to become apparent.

The study, called INFINITY, is the first to demonstrate an effective way to slow the progression of cerebrovascular disease, a condition common in older adults that restricts the flow of blood to the brain. The study is also unique in its use of around-the-clock ambulatory blood pressure monitors, which measured participants' blood pressure during all activities of daily living, rather than only in the medical care environment. In addition to seeing beneficial effects in the brain, those who kept their blood pressure lower also were less likely to suffer major cardiovascular events, such as a heart attack or stroke.

"I think it's an important clinical finding, and a very hopeful one for elderly people who have vascular disease of the brain and hypertension," said William B. White, MD, professor of medicine at the University of Connecticut School of Medicine's Calhoun Cardiology Center and one of the study's principal investigators. "With the intensive 24-hour blood pressure treatment we reduced the accrual of this brain damage by 40 percent in a period of just three years. That is highly clinically significant, and I think over a longer time period intensive reduction of the ambulatory blood pressure will have a substantial impact on function in older persons, as well."

By reducing blood flow to the brain, cerebrovascular disease causes a gradual buildup of lesions that represent areas with damaged nerve cells in the brain's white matter. Older people with more of these lesions tend to have slower reflexes, problems with mobility and more signs of cognitive decline.

Having high systolic blood pressure over a long period of time is known to exacerbate damage to small arteries in the deep regions of the brain, but it was not previously known whether the process could be stopped or slowed by controlling ambulatory blood pressure. The new findings suggest keeping the 24-hour systolic blood pressure around 130 mm Hg is a safe and effective way to slow the progression of the disease, White said.

The trial enrolled 199 people who were an average age of 81 years old. All participants had hypertension at the start of the trial, with an average systolic blood pressure around 150 mm Hg, as well as evidence of some cerebrovascular disease on an MRI scan. Half of the participants were randomly assigned to receive standard blood pressure control and half were assigned to receive more intensive blood pressure control.

Doctors worked closely with each patient to manage their medications until they achieved the target blood pressure. They used ambulatory blood pressure monitors to guide blood pressure treatment. Since blood pressure measurements taken in the clinical environment may not be truly representative of the out-of-office blood pressure, ambulatory blood pressure monitoring is known to provide a more accurate picture of blood pressure behavior, White said.

Patients receiving standard blood pressure control maintained an average systolic blood pressure of 146 mm Hg, close to the study's target level of 145 mm Hg. Patients receiving the more intensive treatment had an average systolic blood pressure of 131 mm Hg, close to the target level of 130 mm Hg.

After three years, those maintaining the lower systolic blood pressure level had about a 40 percent relative reduction in the accumulation of the white matter lesions, the study's first co-primary endpoint, than those with higher blood pressure. However, the groups showed no significant difference in gait speed, a marker of mobility function and the other co-primary endpoint.

A sensitivity analysis showed that 60 percent of the patients maintained their target blood pressure throughout the full three years. An analysis of data from these patients revealed even more pronounced differences in the number of brain lesions among participants with higher versus lower blood pressure. Because this reduction in accrual of brain lesions was so significant, it is reasonable to expect that those in the more intensive treatment group would begin to show benefits over the standard treatment group in mobility and cognitive function after a few more years, White said.

"The average 80-year-old without a major illness such as cancer or heart failure can expect to live about 13 more years, and if you cut back the accrual of vascular damage over the course of that timeframe it could substantially improve a person's quality of life," White said. "In addition, this benefit would likely be amplified in people with more severe or longer-duration hypertension."

Intensive blood pressure control also brought cardiovascular benefits. Even in this small group of 199 patients, participants in the standard therapy group were four times as likely to suffer a major non-fatal cardiovascular event compared with those in the intensive treatment group.

Having blood pressure that is too low can cause a person to faint or have falls with injury. However, the rates of fainting and falling were the same in both treatment groups, suggesting that the 24-hour systolic blood pressure target of 130 mm Hg was not an unacceptably low target, White said.

White said that the study was limited by its relatively small size and the likelihood that three years was not enough time to show measurable cognitive benefits.
-end-
The study was funded by the National Institute of Aging of the National Institutes of Health and the Lowell Weicker General Clinical Research Center at the University of Connecticut.

The ACC's Annual Scientific Session will take place March 16-18, 2019, in New Orleans, bringing together cardiologists and cardiovascular specialists from around the world to share the newest discoveries in treatment and prevention. Follow @ACCinTouch, @ACCMediaCenter and #ACC19 for the latest news from the meeting.

The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its more than 52,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit acc.org.

American College of Cardiology

Related Blood Pressure Articles:

Do you really have high blood pressure?
A study by researchers at the University of Montreal Hospital Research Centre (CRCHUM) shows that more than half of family doctors in Canada are still using manual devices to measure blood pressure, a dated technology that often leads to misdiagnosis.
Why do we develop high blood pressure?
Abnormally high blood pressure, or hypertension, may be related to changes in brain activity and blood flow early in life.
For some, high blood pressure associated with better survival
Patients with both type 2 diabetes and acute heart failure face a significantly lower risk of death but a higher risk of heart failure-related hospitalizations if they had high systolic blood pressure on discharge from the hospital compared to those with normal blood pressure, according to a study scheduled for presentation at the American College of Cardiology's 66th Annual Scientific Session.
$9.4 million grant helps scientists explore how cell death from high blood pressure fuels even higher pressure
It's been known for decades that a bacterial infection can raise your blood pressure short term, but now scientists are putting together the pieces of how our own dying cells can fuel chronically high, destructive pressure.
Blood pressure diet improves gout blood marker
A diet rich in fruits, vegetables, low-fat dairy and reduced in fats and saturated fats (the DASH diet), designed decades ago to reduce high blood pressure, also appears to significantly lower uric acid, the causative agent of gout.
New tool to improve blood pressure measurement
Oxford University researchers have developed a prediction model that uses three separate blood pressure readings taken in a single consultation and basic patient characteristics to give an adjusted blood pressure reading that is significantly more accurate than existing models for identifying hypertension.
Blood vessels sprout under pressure
It is blood pressure that drives the opening of small capillaries during angiogenesis.
Better blood pressure control -- by mobile phone
An interactive web system with the help of your mobile phone can be an effective tool for better blood pressure control.
Time to reassess blood-pressure goals
High blood pressure or hypertension is a major health problem that affects more than 70 million people in the US, and over one billion worldwide.
With help from pharmacists, better blood pressure costs $22
A pharmacist-physician collaboration in primary-care offices effectively and inexpensively improved patients' high blood pressure.

Related Blood Pressure Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".